title: Effect of purification, theophylline and sodium fluoride on histamine release produced by antineoplastic drugs on rat mast cells. A distinctive mechanism of action for carboplatin.
abstract: The antineoplastic drugs, cytarabine, ifosfamide, vinorelbine, doxorubicin, asparaginase and carboplatin, elicit histamine release from rat pleural and peritoneal mast cells. Both cell populations do not show heterogeneity in their response to stimulation by any of these drugs, with the exception of cytarabine, which activates pleural mast cells at lower concentrations. When these cells are purified with Percoll, L-asparaginase, vinorelbine and cytarabine completely lose their capability of inducing histamine release in both cell populations, while the other drugs still show the same pattern of response as with unpurified cells. These results indicate that some membrane component crucial for the action of vinorelbine, L-asparaginase and cytarabine is lost during the purification procedure. Pretreatment of the cells with theophylline completely inhibits the response to cytarabine, ifosfamide, vinorelbine and asparaginase, and inhibits the response to doxorubicin by up to 75% only. Theophylline does not change the response to carboplatin. Sodium fluoride does not change the response to any of the drugs tested, with the exception of carboplatin, in which case a complete inhibition is observed. In conclusion, carboplatin activates rat mast cells through a completely different mechanism of action with respect to the other drugs studied.
authors.affiliation: Servicio de Farmacia, Hospital General de Asturias, Oviedo, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Arnaez
authors.forename: A
authors.initials: A
authors.lastname: Alfonso
authors.forename: M
authors.initials: M
authors.lastname: Estevez
authors.forename: M R
authors.initials: MR
authors.lastname: Vieytes
authors.forename: M C
authors.initials: MC
authors.lastname: Louzao
authors.forename: L M
authors.initials: LM
authors.lastname: Botana
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001215:Asparaginase / Q000494:pharmacology; D016190:Carboplatin / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D002462:Cell Membrane / Q000378:metabolism; D003561:Cytarabine / Q000494:pharmacology; D006632:Histamine / Q000378:metabolism*; D007069:Ifosfamide / Q000494:pharmacology; D008407:Mast Cells / Q000187:drug effects* / Q000378:metabolism; D010529:Peritoneal Cavity; D010994:Pleura; D051381:Rats; D011919:Rats, Inbred Strains; D012969:Sodium Fluoride / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology*; D014747:Vinblastine / Q000031:analogs & derivatives / Q000494:pharmacology; D000077235:Vinorelbine
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; D014747:Vinblastine; D006632:Histamine; D012969:Sodium Fluoride; D016190:Carboplatin; D013806:Theophylline; D001215:Asparaginase; D000077235:Vinorelbine; D007069:Ifosfamide